tiprankstipranks
Gain Therapeutics initiated with a Buy at Roth MKM
The Fly

Gain Therapeutics initiated with a Buy at Roth MKM

Roth MKM analyst Boobalan Pachaiyappan initiated coverage of Gain Therapeutics (GANX) with a Buy rating and $7 price target

Pick the best stocks and maximize your portfolio:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App